Cargando…

The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats

Safranal, the main component of Crocus sativus essential oil, exhibits different pharmacological activities. In this study, the effects of safranal, on blood pressure of normotensive and desoxycorticosterone acetate (DOCA) - salt induced hypertensive rats in chronic administration were investigated....

Descripción completa

Detalles Bibliográficos
Autores principales: Imenshahidi, Mohsen, Razavi, Bibi Marjan, Faal, Ayyoob, Gholampoor, Ali, Mousavi, Seyed Mehran, Hosseinzadeh, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403076/
https://www.ncbi.nlm.nih.gov/pubmed/25901167
_version_ 1782367313468588032
author Imenshahidi, Mohsen
Razavi, Bibi Marjan
Faal, Ayyoob
Gholampoor, Ali
Mousavi, Seyed Mehran
Hosseinzadeh, Hossein
author_facet Imenshahidi, Mohsen
Razavi, Bibi Marjan
Faal, Ayyoob
Gholampoor, Ali
Mousavi, Seyed Mehran
Hosseinzadeh, Hossein
author_sort Imenshahidi, Mohsen
collection PubMed
description Safranal, the main component of Crocus sativus essential oil, exhibits different pharmacological activities. In this study, the effects of safranal, on blood pressure of normotensive and desoxycorticosterone acetate (DOCA) - salt induced hypertensive rats in chronic administration were investigated. Three doses of safranal (1, 2 and 4 mg/Kg/day) and spironolactone (50 mg/Kg/day) were administrated to the different groups of normotensive and hypertensive rats (at the end of 4 weeks treatment by DOCA-salt) for Five weeks. Then the effects of safranal on mean systolic blood pressure (MSBP) and heart rate (HR) were evaluated using tail cuff method. The duration of effect of safranal on SBP, was also evaluated. Our results indicated that chronic administration of safranal could reduce the MSBP in DOCA salt treated rats in a dose dependent manner. Safranal did not decrease the MSBP in normotensive rats. The data also showed that antihypertensive effects of safranal did not persist. In summary, our results showed that safranal exhibits antihypertensive and normalizing effect on BP in chronic administration.
format Online
Article
Text
id pubmed-4403076
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-44030762015-04-21 The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats Imenshahidi, Mohsen Razavi, Bibi Marjan Faal, Ayyoob Gholampoor, Ali Mousavi, Seyed Mehran Hosseinzadeh, Hossein Iran J Pharm Res Original Article Safranal, the main component of Crocus sativus essential oil, exhibits different pharmacological activities. In this study, the effects of safranal, on blood pressure of normotensive and desoxycorticosterone acetate (DOCA) - salt induced hypertensive rats in chronic administration were investigated. Three doses of safranal (1, 2 and 4 mg/Kg/day) and spironolactone (50 mg/Kg/day) were administrated to the different groups of normotensive and hypertensive rats (at the end of 4 weeks treatment by DOCA-salt) for Five weeks. Then the effects of safranal on mean systolic blood pressure (MSBP) and heart rate (HR) were evaluated using tail cuff method. The duration of effect of safranal on SBP, was also evaluated. Our results indicated that chronic administration of safranal could reduce the MSBP in DOCA salt treated rats in a dose dependent manner. Safranal did not decrease the MSBP in normotensive rats. The data also showed that antihypertensive effects of safranal did not persist. In summary, our results showed that safranal exhibits antihypertensive and normalizing effect on BP in chronic administration. Shaheed Beheshti University of Medical Sciences 2015 /pmc/articles/PMC4403076/ /pubmed/25901167 Text en © 2015 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Imenshahidi, Mohsen
Razavi, Bibi Marjan
Faal, Ayyoob
Gholampoor, Ali
Mousavi, Seyed Mehran
Hosseinzadeh, Hossein
The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats
title The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats
title_full The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats
title_fullStr The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats
title_full_unstemmed The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats
title_short The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats
title_sort effect of chronic administration of safranal on systolic blood pressure in rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403076/
https://www.ncbi.nlm.nih.gov/pubmed/25901167
work_keys_str_mv AT imenshahidimohsen theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT razavibibimarjan theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT faalayyoob theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT gholampoorali theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT mousaviseyedmehran theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT hosseinzadehhossein theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT imenshahidimohsen effectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT razavibibimarjan effectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT faalayyoob effectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT gholampoorali effectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT mousaviseyedmehran effectofchronicadministrationofsafranalonsystolicbloodpressureinrats
AT hosseinzadehhossein effectofchronicadministrationofsafranalonsystolicbloodpressureinrats